4-Meter Gait Speed Test in Chronic Obstructive Pulmonary Disease

Bisca, Gianna Waldrich; Fava, Lucas Rodrigues; Morita, Andrea Akemi; Machado, Felipe; Pitta, Fábio; Hernandes, Nídia A.

doi:10.1097/hcr.0000000000000297

Cited by 9 publications

(8 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The time to walk 10 meters was measured in seconds with a stopwatch, a method earlier shown to be reliable. 13 The time to finish the 10-meter gait speed test was converted to velocity in meters per second as follows: 10-meter gait speed (m/s) = 10 m/seconds to finish walking test.…”

Section: The 10-meter Gait Speed Testmentioning

confidence: 99%

<p>Gait Speed at Discharge and Risk for Readmission or Death: A Prospective Study of an Emergency Ward Population</p>

Hertzberg

Luksha

Kus

et al. 2020

OAEM

View full text Add to dashboard Cite

show abstract

Section: The 10-meter Gait Speed Testmentioning

confidence: 99%

<p>Gait Speed at Discharge and Risk for Readmission or Death: A Prospective Study of an Emergency Ward Population</p>

Hertzberg

Luksha

Kus

et al. 2020

OAEM

View full text Add to dashboard Cite

show abstract

“…• Inter-rater reliability very strong inter-rater reliability reported in older patients with COPD ICC value of 0.99 (95% CI 0.98-0.99)[48,50].• Responsiveness the 4-m gait speed is responsive to clinically meaningful changes with 0.05 m/s denoting a small change (i.e. clinically detectable, potentially important) and 0.1 m/s indicating a substantial change (clinically detectable, definitely important) [51].…”

mentioning

confidence: 99%

Assessment of Muscle Function and Physical Performance in Daily Clinical Practice

et al. 2019

View full text Add to dashboard Cite

It is well recognized that poor muscle function and poor physical performance are strong predictors of clinically relevant adverse events in older people. Given the large number of approaches to measure muscle function and physical performance, clinicians often struggle to choose a tool that is appropriate and validated for the population of older people they deal with. In this paper, an overview of different methods available and applicable in clinical settings is proposed. This paper is based on literature reviews performed by members of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) working group on frailty and sarcopenia. Face-to-face meetings were organized afterwards where the whole group could amend and discuss the recommendations further. Several characteristics should be considered when choosing a tool: (1) purpose of the assessment (intervention, screening, diagnosis); (2) patient characteristics (population, settings, functional ability, etc.); (3) psychometric properties of the tool (test-retest reliability, inter-rater reliability, responsiveness, floor and ceiling effects, etc.); (4) applicability of the tool in clinical settings (overall cost, time required for the examination, level of training, equipment, patient acceptance, etc.); (5) prognostic reliability for relevant clinical outcomes. Based on these criteria and the available evidence, the expert group advises the use of grip strength to measure muscle strength and the use of 4-m gait speed or the Short Physical Performance Battery test to measure physical performance in daily practice. The tools proposed are relevant for the assessment of muscle weakness and physical performance. Subjects with low values should receive additional diagnostic workups to achieve a full diagnosis of the underlying condition responsible (sarcopenia, frailty or other).

show abstract

“…Gait speed tests and timed “up and go tests” have been used extensively to identify early motor impairment in several conditions, and the association between these measures and future falls and hospitalization has been well established . In particular, slow gait speed has been consistently associated with the development of Alzheimer's disease, even in its early stages, that is, with cerebral Αβ deposition .…”

Section: Discussionmentioning

confidence: 99%

“…Gait speed tests and timed "up and go tests" have been used extensively to identify early motor impairment in several conditions, and the association between these measures and future falls and hospitalization has been well established. [28][29][30]36,41,[44][45][46][47][48] In particular, slow gait speed has been consistently associated with the development of Alzheimer's disease, [49][50][51] even in its early stages, that is, with cerebral Αβ deposition. 52 Objective motor function in our study, as captured by the 1-m and 4-m gait tests, was associated with the pPD probability score even when calculated excluding UPDRSIII and even when participants with dementia or both dementia and MCI or with previous stroke were excluded from the analysis.…”

Section: Discussionmentioning

confidence: 99%

Motor function and the probability of prodromal Parkinson's disease in older adults

et al. 2019

View full text Add to dashboard Cite

Background Identification and characterization of Parkinson's disease (PD) in its prodromal stage is crucial. Objective The objective of this study was to investigate the association between motor function and the probability of prodromal PD in a community‐dwelling older population. Methods We used data from a population‐based cohort of older adults (HELIAD study). Subjective motor function was evaluated with a 12‐item motor symptoms questionnaire and objective motor function indirectly with a physical activity questionnaire and two gait speed tests. The probability of prodromal PD was calculated according to the Movement Disorder Society research criteria for n = 1731 without PD. Regression multiadjusted models were used to investigate the associations between each motor measure and prodromal PD probability. Results For each unit increase in motor symptoms score and for each kcal/kg/day lower energy expenditure (corresponding to 20 minutes of light walking/day for a 75‐kg man) there was a 27% and 3% higher probability for prodromal PD, respectively (P < 0.001). Having at least one subjective motor symptom increased the odds of having possible/probable prodromal PD (n = 49; P < 0.05). Including subjective and indirect motor variables in the same model showed that both (symptoms and physical activity) contributed significantly to the model (P < 0.01). Excluding subthreshold parkinsonism from the calculation showed that gait speed less than 0.8 m/s was also associated with a higher prodromal PD probability score (P < 0.001). Conclusions Subjective motor symptoms as well as simple objective motor measures of physical activity or gait speed are associated with a higher probability of prodromal PD in older adults. These data may serve to enable the early identification of prodromal PD cohorts, particularly if they are confirmed in longitudinal studies. © 2019 International Parkinson and Movement Disorder Society

show abstract

4-Meter Gait Speed Test in Chronic Obstructive Pulmonary Disease

Abstract: The stopwatch, a low-cost and feasible tool, is reliable as a timing device for the 4MGS in patients with chronic obstructive pulmonary disease.

Cited by 9 publications

References 9 publications

<p>Gait Speed at Discharge and Risk for Readmission or Death: A Prospective Study of an Emergency Ward Population</p>

<p>Gait Speed at Discharge and Risk for Readmission or Death: A Prospective Study of an Emergency Ward Population</p>

Assessment of Muscle Function and Physical Performance in Daily Clinical Practice

Motor function and the probability of prodromal Parkinson's disease in older adults

Contact Info

Product

Resources

About